Skip to main content
. 2020 Sep 16;100:476–482. doi: 10.1016/j.ijid.2020.09.025

Table 2.

Results of rRT-qPCR tests of materials collected by air samplers.

Sample ID Approx. distance (m) from head of patient 1b Approx. distance (m) from head of patient 2b rRT-qPCR test Cq value SARS-CoV-2 genome equivalents/25 μL rRT-PCR test SARS-CoV-2 genome equivalents/L of air
1-1 BioSpot 2 4.6 + 36.02 2.82E+03 94
1-2 BioSpot + HEPA 2 4.6 - - - -
1-3 BioSpot 2 0 (PDb) + 37.69 9.12E+02 30
2-1 VIVAS 4.8 3 + 37.42 1.15E+03 44
2-2 VIVAS+ HEPA 4.8 3 - - - -
2-3 VIVAS 4.8 0 (PDd) + 38.69 4.68E+02 16
SARS-CoV-2 vRNA N/Ac N/A + 29.53 2.20E+05 N/A
N-genea DNA control - 1 N/A N/A + 26.56 1.00E+06 N/A
N-gene DNA control - 2 N/A N/A + 31.21 1.00E+05 N/A
N-gene DNA control - 3 N/A N/A + 34.71 1.00E+04 N/A
N-gene DNA control -4 N/A N/A + 37.74 1.00E+03 N/A
N-gene DNA control - 5 N/A N/A + 40.41 1.00E+02 N/A
N-gene DNA control - 6 N/A N/A + - 1.00E+01 N/A
Known positive (NP swabe) N/A N/A + 24.12 8.36E+06 N/A
Negative (no RNA) control N/A N/A N/A - 0 N/A
a

N-gene, N-gene plasmid (positive control template).

b

Distance from sampler inlet nozzle to patient’s head.

c

N/A, Not applicable.

d

PD, patient discharged.

e

NP, Nasopharyngeal swab from a person screened for SARS-CoV-2 at the UF EPI high-throughput COVID-19 research testing facility.